Kit ELISA DAN sandwich (PARN) (mouse): quantitative dosage of Ms DAN in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Ms DAN.
Accession number
Q8 VDG3
Dose range
40.96-10.000 pg/ml
Sensitivity of the dosage
35 pg/ml
Calibration range
35 pg/ml to 10.000 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA DAN sandwich (PARN) (mouse): quantitative dosage of Ms DAN in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Ms DAN.
Kit ELISA DAN sandwich (PARN) (mouse): quantitative dosage of Ms DAN in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Ms DAN.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
The protein encoded by this gene is a 3′-exoribonuclease, similar to the family RNase D of the 3′-exonucleases. It prefers poly(A) because the substrate effectively degrades the poly(A) tails of mRNA. Exonucleolytic degradation of the poly(A) tail is often the first step in the decline of the eukaryotic mRNA. This protein is also involved in the neutralization of some maternal mRNAs during oocyte maturation and early embryonic development, as well as in the nonsense-induced degradation (NMD) of mRNAs containing premature stopping codons. Alternative splicing transcription variants coding different isoforms were also discovered for this gene.